You are using an outdated browser!

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

Tuesday Pre-Courses

One-Day Pre-Courses

Tuesday, April 21

Register for Pre-Courses

PRE 2001 Dermatology for the Internist

Tuesday, 8:00 a.m.-5:00 p.m.

Jennie T. Clarke, MD
Associate Professor of Dermatology, Department of Dermatology,
University of Utah School of Medicine, Salt Lake City, UT

Patients often present to their internist with skin concerns. Many of these concerns are common conditions that, once identified, can be easily addressed without a referral to a dermatologist. With the aid of an audience-response system, faculty will engage participants in identifying many of these common dermatologic conditions and will review appropriate steps for their diagnosis and management in the primary care setting. Practical approaches, including biopsy techniques, will be reviewed.

Learning Objectives:

  1. Identify common dermatologic problems that present in the primary care setting, and initiate appropriate treatment.
  2. Understand and develop treatment strategies for patients with acne and rosacea.
  3. Identify and develop management approaches for both common and complicated dermatoses, such as psoriasis.
  4. Recognize common skin cancers and understand indications for various approaches to management.

PRE 2002 Diabetes for the Internist

Tuesday, 8:00 a.m.-5:00 p.m.

Tracy L. Setji, MD, MHS, Member
Associate Professor of Medicine, Department of Medicine, Division of Endocrinology,
Duke University Medical Center, Durham, NC

Several advancements in medications, technologies, and surgical options can markedly improve the health of our patients with diabetes, but these advancements also increase the complexity of disease treatment. This Pre-Course will discuss the diagnosis of prediabetes and diabetes, including less common forms such as maturity-onset diabetes of the young (MODY) and latent autoimmune diabetes in adults (LADA). Faculty will review the role of lifestyle interventions as well as appropriate indications and practical utilization of weight-loss medications and/or bariatric surgery in overweight patients with diabetes. The risks and benefits of new insulin and noninsulin pharmacologic therapies will be presented. The role of diabetes medications, cholesterol-lowering agents, and blood pressure control to reduce cardiovascular risk will be discussed.

Learning Objectives:

  1. Review the management of patients with prediabetes, including when to use metformin.
  2. Discuss the role of nutrition, weight-loss agents, and bariatric surgery in overweight patients with diabetes.
  3. Review new insulin products and diabetes technology, including pumps and sensors, and specifically address when these advancements may help your patients with type 1 and 2 diabetes.
  4. Using a case-based approach, review guideline-based medical management of type 2 diabetes with a focus on the risks and benefits of recently approved noninsulin therapies.
  5. Provide guidance on the evaluation, classification, and treatment of less common causes of diabetes, such as monogenic diabetes syndromes as well as autoimmune and medication-induced diabetes.
  6. Discuss the prevention and treatment of cardiovascular disease in patients with diabetes.
  7. Within a panel discussion format, review questions and challenges that arise in your clinic.

PRE 2003 Perioperative Medicine 2020

Tuesday, 8:00 a.m.-5:00 p.m.

Geno J. Merli, MD, FHM, FSVM, MACP
Professor, Medicine & Surgery, Associate Chief Medical Officer, Senior Vice President,
Division of Vascular Medicine, Vascular Center, Thomas Jefferson University Hospitals, Philadelphia, PA

This Pre-Course will review the assessment and management of patients with medical comorbidities undergoing surgical procedures. Expert faculty will discuss postoperative nausea and vomiting, preoperative blood pressure control, and fasting prior to surgery. Venous thromboembolism (VTE) prophylaxis in the postoperative period for patients with renal impairment, hereditary or acquired coagulation disorders, history recurrent VTE, the best VTE prophylaxis in joint replacement surgery will be reviewed. Preoperative validated risk assessment tools, mitigation strategies for identified comorbidities, and management of postoperative complications will be emphasized. Topics will include perioperative medication management; cardiac, pulmonary, and frailty risk indices with modification strategies; postoperative cardiac complications; managing cannabis, suboxone, methadone; using the target-specific anticoagulants; treating postoperative delirium and challenging perioperative cases.

Learning Objectives:

  1. Understand the assessment and management of patients with medical comorbidities undergoing inpatient and outpatient surgical procedures.
  2. Review guidelines and best practices for preoperative laboratory testing, perioperative medication use, and common anesthesia related issues.
  3. Review preoperative validated risk assessment tools, strategies to mitigate risk, and management of patients with a variety of pre- and post-surgery cardiac and pulmonary problems as well as postoperative complications in the frail elderly.
  4. Understand management of cardiac indicated antiplatelet agents and the appropriate use of direct oral anticoagulants (DOACs) in the perioperative period, which will include rescue and reversal agents for emergent surgery.
  5. Assess key management strategies for the alcohol dependent patient, postoperative pain management, and drug dependent patient.

PRE 2004 Pregnancy for the Internist: Before, During, and After

Tuesday, 8:00 a.m.-5:00 p.m.

Lucia Larson, MD, FACP
Director, Obstetric Medicine, Women's Medicine Collaborative, Associate Professor,
Department of Medicine, Alpert Medical School of Brown University, Providence, RI

Internists have an important role in the care of women across the lifespan. This role has become more important around pregnancy as maternal mortality in the United States increases and women delay childbearing until they are older when they enter pregnancy with more disorders, such as hypertension, obesity, and diabetes. Although the obstetrician is comfortable with pregnancy, internists have special expertise in managing medical problems. This Pre-Course will provide key principles for internists caring for women with medical disorders prior to pregnancy to optimize pregnancy outcome. Through case-based learning with an audience-response system, important physiologic changes in pregnancy, the appropriate use of medication and diagnostic imaging, and the assessment and management of common medical problems in pregnancy will be illustrated. Postpartum disorders and issues regarding lactation and medication use will be addressed. The opportunity to identify future health risks and prevention interventions on the basis of pregnancy events will be highlighted.

Learning Objectives:

  1. Describe the important physiologic changes in pregnancy that impact medical illness and understand the appropriate use of medication and diagnostic imaging in the pregnant woman.
  2. Provide the internist with a framework for preconception counseling and optimizing common medical diseases in anticipation of pregnancy.
  3. Review how the management of common medical disease in pregnancy differs from that in the nonpregnant patient (e.g., hypertension, diabetes, thrombosis, thyroid disease, depression).
  4. Outline important concepts of breastfeeding and the use of medication and diagnostic imaging in breastfeeding women.
  5. Recognize the importance of pregnancy and postpartum disorders in predicting future health risks for women.

PRE 2005 MAT (Medication-Assisted Treatment) Waiver Training Workshop

Presented by the Providers Clinical Support System

Tuesday, 8:00 a.m.-5:00 p.m.

Sarah G. Candler, MD, MPH, FACP
Division of Internal Medicine, Department of Primary Care, Iora Primary Care, Houston, TX

Buprenorphine is a safe and effective component of medication-assisted treatment (MAT) for opioid use disorder. Although buprenrophine can easily be prescribed in outpatient settings, access to therapy is limited for many patients in part because most clinicians lack waiver certifications to prescribe it. MAT is associated with decreased opioid use, decreased opioid-related and all-cause mortality, improved health care engagement, and improved quality of life. Under the Drug Addiction Treatment Act (DATA) of 2000, prescribers must obtain a specialized “X waiver” certification to prescribe buprenorphine for the treatment of opioid use disorder.

Participants will complete the requisite coursework to obtain a buprenorphine “X waiver” certification. This Pre-Course will include 8 hours of in-person didactics led by certified trainers, which will fulfill the entire 8-hour training required to apply for a waiver to prescribe buprenorphine for treatment of opioid use disorder. Instructors will deliver core content mandated by the federal training requirement, facilitate connection to mentors, provide patient and clinician materials, and review current local and national policies guiding MAT for opioid use disorder.

Learning Objectives:

At the conclusion of this activity participants should be able to:

  1. Review addiction treatment in office-based practices.
  2. Discuss the pharmacological treatments of opioid use disorder.
  3. Determine what medical record documentation must be followed.
  4. Discuss the process of buprenorphine induction as well as stabilization and maintenance techniques.
  5. Describe how to take a patient history and evaluation.
  6. Review safety concerns and drug interactions.

The American Academy of Addiction Psychiatry is the Data Sponsor for this activity.

The American Academy of Addiction Psychiatry is approved by the Drug Abuse Treatment Act of 2000 (DATA) to provide the required eight-hour training that qualifies physicians for the waiver to prescribe Buprenorphine for treating opioid use disorders.

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

PCSS

This Pre-Course is organized and presented by the Providers Clinical Support System. Category 1 CME credit will be provided by the American Academy of Addiction Psychiatry and not the American College of Physicians. The American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. In 2019, AAAP also added accreditation from The American Academy of PAs (AAPA), American Psychological Association (APA) and Association for Social Work Boards (ASWB).

Instructions for claiming credit through the American Academy of Addiction Psychiatry will be provided at the Pre-Course.

 Return to full list of Pre-Courses